Plasma Cell-Free DNA and Caspase-3 Levels in Patients with Chronic Kidney Disease

被引:0
|
作者
Clementi, Anna [1 ,2 ]
Virzi, Grazia Maria [2 ,3 ]
Manani, Sabrina Milan [2 ,3 ]
de Cal, Massimo [2 ,3 ]
Battaglia, Giovanni Giorgio
Ronco, Claudio [3 ]
Zanella, Monica [2 ,3 ]
机构
[1] Santa Marta & Santa Venera Hosp, Dept Nephrol & Dialysis, I-95024 Acireale, Italy
[2] IRRIV Int Renal Res Inst, I-36100 Vicenza, Italy
[3] St Bortolo Hosp, Dept Nephrol Dialysis & Transplant, I-36100 Vicenza, Italy
关键词
cell free DNA; caspase-3; chronic kidney disease; HEMODIALYSIS; APOPTOSIS;
D O I
10.3390/jcm12175616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cell-free plasma DNA (cfDNA) is circulating extracellular DNA arising from cell death mechanisms (apoptosis, necrosis, etc.). It is commonly existent in healthy individuals, but its ranks increase in diverse clinical circumstances, such as kidney disease, sepsis, myocardial infarction, trauma and cancer. In patients with advanced chronic kidney disease, cfDNA is connected to inflammation, and it has been associated with higher mortality. Caspase-3 plays a dominant role in apoptosis, a mechanism of programmed cell death involved in the pathogenesis and progression of chronic kidney disease (CKD). The aim of this pilot study was the evaluation of cfDNA levels and caspase-3 concentrations in patients with chronic kidney disease, in order to investigate the potential role of these molecules, deriving from inflammatory and apoptotic mechanisms, in the progression of renal damage. Methods: We compared cfDNA and caspase-3 levels in 25 CKD patients and in 10 healthy subjects, evaluating their levels based on CKD stage. We also explored correlations between cfDNA and caspase-3 levels in CKD patients and between cfDNA and caspase-3 levels and serum creatinine and urea in this population. Results: We observed that cfDNA and caspase-3 levels were higher in patients with CKD compared to healthy subjects, in particular in patients with advanced renal disease (CKD stage 5). A positive correlation between cfDNA and caspase-3 levels and between cfDNA and caspase-3 and creatinine and urea were also noticed. Conclusions: Patients with chronic kidney disease show higher levels of cfDNA and caspase-3 levels compared to the control group. Based on these preliminary results, we speculated that the worsening of renal damage and the increase in uremic toxin concentration could be associated with higher levels of cfDNA and caspase-3 levels, thus reflecting the potential role of inflammation and apoptosis in the progression of CKD. Future studies should focus on the validation of these promising preliminary results.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease
    Korabecna, Marie
    Opatrna, Sylvie
    Wirth, Jan
    Rulcova, Kamila
    Eiselt, Jaromir
    Sefrna, Frantisek
    Horinek, Ales
    CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V, 2008, 1137 : 296 - 301
  • [2] Erythrocyte caspase-3 levels in children with chronic kidney disease
    Polak-Jonkisz, D.
    Purzyc, L.
    Szczepanska, M.
    Makulska, I.
    CLINICAL BIOCHEMISTRY, 2013, 46 (03) : 219 - 224
  • [3] Cell-free DNA as a plausible biomarker of chronic kidney disease
    Berezina, Tetiana A.
    Berezin, Alexander E.
    EPIGENOMICS, 2023, 15 (17) : 879 - 890
  • [4] The Impact of Chronic Kidney Disease and Short-Term Treatment with Rosiglitazone on Plasma Cell-Free DNA Levels
    McGuire, Amanda L.
    Urosevic, Nadia
    Chan, Doris T.
    Dogra, Gursharan
    Inglis, Timothy J. J.
    Chakera, Aron
    PPAR RESEARCH, 2014, 2014
  • [5] Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations
    Avriel, Avital
    Rozenberg, Dmitry
    Raviv, Yael
    Heimer, Dov
    Bar-Shai, Amir
    Gavish, Rachel
    Sheynin, Jony
    Douvdevani, Amos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 3153 - 3161
  • [6] Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathy
    Zaravinos, Apostolos
    Tzoras, Spiros
    Apostolakis, Stavros
    Lazaridis, Kyriakos
    Spandidos, Demetrios A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (02) : 180 - 187
  • [7] Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation
    Leotta, Chiara
    Hernandez, Leah
    Tothova, Lubomira
    Arefin, Samsul
    Ciceri, Paola
    Cozzolino, Mario Gennaro
    Barany, Peter
    Chromek, Milan
    Stenvinkel, Peter
    Kublickiene, Karolina
    CELLS, 2023, 12 (24)
  • [8] Plasma Cell-Free DNA Levels in Children on Peritoneal Dialysis
    Ozkaya, O.
    Bek, K.
    Bedir, A.
    Acikgoz, Y.
    Ozdemir, T.
    NEPHRON CLINICAL PRACTICE, 2009, 113 (04): : C258 - C261
  • [9] Effects of cell-free DNA on kidney disease and intervention strategies
    Zhang, Mingying
    Cai, Yubin
    Zhong, Xiaoze
    Liu, Weijun
    Lin, Yuan
    Qiu, Zhanyi
    Liang, Ruihuang
    Wei, Huibo
    Wu, Kefei
    Liu, Qinghua
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [10] Spermine triggers the activation of caspase-3 in a cell-free model of apoptosis
    Stefanelli, C
    Bonavita, F
    Stanic, I
    Pignatti, C
    Flamigni, F
    Guarnieri, C
    Caldarera, CM
    FEBS LETTERS, 1999, 451 (02) : 95 - 98